NASDAQ:GYRO Gyrodyne (GYRO) Stock Price, News & Analysis → Investors Alert: The Next Big Thing in Weight Loss (From Behind the Markets) (Ad) Free GYRO Stock Alerts $7.94 +0.15 (+1.93%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$7.93▼$7.9450-Day Range$7.79▼$8.3952-Week Range$7.79▼$12.66Volume457 shsAverage Volume2,738 shsMarket Capitalization$17.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Gyrodyne alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Gyrodyne Stock (NASDAQ:GYRO)Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.Read More GYRO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GYRO Stock News HeadlinesApril 19, 2024 | insidertrades.comInsider Buying: Gyrodyne, LLC (NASDAQ:GYRO) Major Shareholder Buys 2,434 Shares of StockApril 5, 2024 | insidertrades.comGyrodyne, LLC (NASDAQ:GYRO) Director Paul L. Lamb Sells 4,368 SharesMay 4, 2024 | Behind the Markets (Ad)Investors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.April 27, 2024 | americanbankingnews.comGyrodyne (NASDAQ:GYRO) Share Price Crosses Below 200 Day Moving Average of $8.93March 8, 2024 | markets.businessinsider.comGYRODYNE ANNOUNCES CLOSING OF SUCCESSFUL, OVERSUBSCRIBED RIGHTS OFFERINGMarch 8, 2024 | globenewswire.comGYRODYNE ANNOUNCES CLOSING OF SUCCESSFUL, OVERSUBSCRIBED RIGHTS OFFERINGFebruary 10, 2024 | markets.businessinsider.comGyrodyne’s Subdivision Approval Faces Legal ChallengesFebruary 7, 2024 | msn.comGyrodyne Announces Rights Offering to Engage InvestorsMay 4, 2024 | Behind the Markets (Ad)Investors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.February 6, 2024 | finance.yahoo.comGYRODYNE ANNOUNCES COMMENCEMENT OF RIGHTS OFFERINGJanuary 22, 2024 | finance.yahoo.comGYRODYNE ANNOUNCES RECORD DATE FOR PROPOSED RIGHTS OFFERINGNovember 29, 2023 | benzinga.comMassive Insider Trade At GyrodyneNovember 17, 2023 | msn.comBizarre Heliplane: A Look At The Fairey RotodyneOctober 30, 2023 | 247wallst.comThe 25 Helicopters of the Vietnam WarSeptember 6, 2023 | msn.comGyrodyne enters into agreement with Star Equity FundSeptember 6, 2023 | finance.yahoo.comGyrodyne Announces Agreement with Star Equity FundAugust 1, 2023 | finance.yahoo.comGyrodyne Appoints Jan Loeb to Board of DirectorsJune 22, 2023 | marketwatch.comStar Equity Fund Responds to Gyrodyne Board's Entrenchment TacticsJune 21, 2023 | finance.yahoo.comStar Equity Fund Responds to Gyrodyne Board’s Entrenchment TacticsApril 28, 2023 | finance.yahoo.comGyrodyne Confirms Receipt of Star Equity’s Notice of Intent to Nominate Two Director Candidates at the 2023 Annual MeetingApril 28, 2023 | finance.yahoo.comStar Equity Fund Announces Nomination of Director Candidates at Gyrodyne, LLCMarch 31, 2023 | msn.comSpirit AeroSystems to work on vertical takeoff aircraft developmentMarch 29, 2023 | finance.yahoo.comGYRODYNE ANNOUNCES CORTLANDT MANOR APPROVAL OF MEDICAL ORIENTED ZONING DISTRICTMarch 28, 2023 | finanznachrichten.deSpirit AeroSystems, Inc.: Spirit, Skyworks Aeronautics Sign Agreement to Pursue Development of Defence and Commercial PlatformsMarch 28, 2023 | finance.yahoo.comSpirit, Skyworks Aeronautics Sign Agreement to Pursue Development of Defence and Commercial PlatformsMarch 28, 2023 | msn.comSpirit AeroSystems Belfast signs agreement to pursue development of defence and commercial platforms in the UK and EuropeJanuary 30, 2023 | finance.yahoo.comGyrodyne Issues Letter to ShareholdersSee More Headlines Receive GYRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gyrodyne and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/04/2024Next Earnings (Estimated)5/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Nonresidential building operators Sub-IndustryDiversified REITs Current SymbolNASDAQ:GYRO CUSIP40382010 CIK1589061 Webwww.gyrodyne.com Phone(631) 584-5400Fax631-584-7075Employees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.36 Current Ratio0.84 Quick Ratio0.84 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$19.51 per share Price / Book0.41Miscellaneous Outstanding Shares2,200,000Free Float2,111,000Market Cap$17.47 million OptionableNot Optionable Beta0.52 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Gary Jay Fitlin (Age 59)President, CEO, CFO & Treasurer Comp: $260kMr. Peter Pitsiokos (Age 64)Chief Compliance Officer, COO, Executive VP & Corporate Secretary Comp: $210kMr. Dawn IbrahamControllerKey CompetitorsThe Herzfeld Caribbean Basin FundNASDAQ:CUBAAshfordNYSE:AINCMill City Ventures IIINASDAQ:MCVTXinyuan Real EstateNYSE:XINEquus Total ReturnNYSE:EQSView All CompetitorsInsiders & InstitutionsTowerview LlcBought 424 shares on 5/1/2024Total: $3,319.92 ($7.83/share)Towerview LlcBought 2,434 shares on 4/16/2024Total: $19,082.56 ($7.84/share)Paul L LambSold 4,368 sharesTotal: $34,900.32 ($7.99/share)Teton Advisors Inc.Sold 2,600 shares on 2/13/2024Ownership: 1.015%View All Insider TransactionsView All Institutional Transactions GYRO Stock Analysis - Frequently Asked Questions How have GYRO shares performed in 2024? Gyrodyne's stock was trading at $10.00 on January 1st, 2024. Since then, GYRO shares have decreased by 20.6% and is now trading at $7.94. View the best growth stocks for 2024 here. Are investors shorting Gyrodyne? Gyrodyne saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 7,600 shares, an increase of 81.0% from the March 31st total of 4,200 shares. Based on an average daily volume of 2,600 shares, the days-to-cover ratio is presently 2.9 days. Currently, 0.7% of the company's shares are sold short. View Gyrodyne's Short Interest. When is Gyrodyne's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Sunday, May 12th 2024. View our GYRO earnings forecast. What other stocks do shareholders of Gyrodyne own? Based on aggregate information from My MarketBeat watchlists, some companies that other Gyrodyne investors own include Acasti Pharma (ACST), Amyris (AMRS), Ariad Pharmaceuticals (ARIA), Astrotech (ASTC), Athersys (ATHX), (AVNR) (AVNR), Bank of America (BAC), Citigroup (C), China Auto Logistics (CALI) and (CHTP) (CHTP). How do I buy shares of Gyrodyne? Shares of GYRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GYRO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyrodyne, LLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
